Entasis Therapeutics (Ireland) Limited – Trademark Portfolio
Entity Type: 99
Entasis Therapeutics (Ireland) Limited holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 7 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 5 trademarks are registered and 1 is pending. Notable registered marks include ZOLNUVEI, ZOLNUVIC, and NUZOLVENCE. The owner is based in Dublin 4.
Barrow Street
6th Floor, South Bank House
Dublin 4 , IE
Showing of trademarks Trademarks
Trademark Classifications
Entasis Therapeutics (Ireland) Limited's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Entasis Therapeutics (Ireland) Limited have?
Entasis Therapeutics (Ireland) Limited has 7 U.S. trademarks filed with the USPTO. Of these, 5 registered, 1 pending, 1 abandoned.
What trademark classes does Entasis Therapeutics (Ireland) Limited file in?
Entasis Therapeutics (Ireland) Limited files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Entasis Therapeutics (Ireland) Limited's most well-known trademarks?
Entasis Therapeutics (Ireland) Limited's registered trademark portfolio includes well-known marks such as ZOLNUVEI, ZOLNUVIC, and NUZOLVENCE. These are among 5 currently registered trademarks in the portfolio.
What is Entasis Therapeutics (Ireland) Limited's trademark registration success rate?
Entasis Therapeutics (Ireland) Limited has a 83% trademark registration rate, with 5 out of 6 resolved applications resulting in successful registration. Currently, 1 application is pending review.